Status:
UNKNOWN
Multisystem Inflammatory Syndrome In Children at Sohag University Hospital
Lead Sponsor:
Sohag University
Conditions:
Multisystem Inflammatory Syndrome in Children
Eligibility:
All Genders
1-12 years
Brief Summary
Since its initial description in December 2019 in Wuhan , China, Corona virus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), has rapid...
Eligibility Criteria
Inclusion
- Any suspected case of MIS-C from birth to 12 year included both sexes fulfill criteria of MIS-C (WHO) .
- Fever for ≥3 days.
- Clinical signs of multi system involvement (at least 2 of the following):
- Rash, bilateral non purulent conjunctivitis, or mucocutaneou inflammation signs (oral, hands, or feet)
- Hypotension or shock
- Cardiac dysfunction, pericarditis, valvulitis , or coronary abnormalities (including echocardiographic findings or elevated troponin)
- Evidence of coagulopathy (prolonged PT or PTT)
- Acute gastrointestinal symptoms (diarrhea , vomiting, or abdominal pain)
- 4\. Elevated markers of inflammation (eg ESR, CRP) 5. No other obvious microbial cause of inflammation. 6. Evidence of SARS-CoV-2 infection (Any of the following: Positive SARS-CoV-2 RT-PCR ,positive serology, COVID 19 exposure within the 4 weeks prior to the onset of symptoms).
- according to CDC criteria exposure to a patients with suspected or confirmed COVID-19 within the 4 weeks prior to the onset of symptoms.
Exclusion
- Other obvious microbial cause of inflammation, including bacterial sepsis and staphylococcal/streptococcal toxic shock syndromes.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05382234
Start Date
June 1 2022
End Date
June 1 2023
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university hospital
Sohag, Egypt